Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


President Signs FDA User Fee Legislation


 
Sen. Lamar Alexander

On Aug. 18, President Donald Trump signed bipartisan legislation authored by Senate health committee Chairman Lamar Alexander (R-Tenn.) and Ranking Member Patty Murray (D-Wash.) intended to speed safe drugs and medical devices into patients' medicine cabinets and doctors' offices, while maintaining safety and effectiveness standards.

"The legislation signed by the president today will speed the FDA's work to review new cures and treatments and get them into patients' medicine cabinets and doctors' offices," Alexander said after the legislation was signed. "The first step was last year's passage of 21st Century Cures to spur medical research, and this is the next step -- legislation to help ensure that these breakthroughs in research make it to patients."

"I'm pleased that Democrats and Republicans in Congress were able to set aside partisanship, work together to put patients and families first, and ensure the FDA continues to have the resources it needs to advance safe, effective medical products for people across the country," Murray said. "This legislation reflects years of hard work by the Obama Administration, as well as members on both sides of the aisle, and I want to express my appreciation in particular to Chairman Alexander for his leadership. I hope we can build on this step forward with additional efforts to strengthen healthcare for the communities we all serve."

The legislation was passed by the Senate on Aug. 3 by a vote of 94-1.

The legislation includes four different user fee agreements that must be reauthorized by Sept. 30. The bill is virtually identical to legislation overwhelmingly approved by the Senate's health committee on May 11. This legislation will reauthorize the authority for the Food and Drug Administration (FDA) to accept user fees - paid by manufacturers of drugs and medical devices - that account for $8 to $9 billion over 5 years and is over a quarter of all FDA funding. The reauthorizations are based on recommendations from industry and FDA after a public process.

Over the last two years, the HELP Committee led by Alexander and Murray has held 15 bipartisan briefings, including some with the House Energy and Commerce Committee, to hear from FDA and industry about the reauthorization. The HELP Committee held two bipartisan hearings, on March 21 and April 4, on the medical device and drug user fees. The committee held a markup on the bill on May 11, when two bipartisan amendments were adopted, and the committee overwhelmingly approved the bill -- voting 21 to 2.

 
Share:

Related Articles:


Recent Articles

Study Challenges Idea That Lower BMI Shields Smokers from Fat-associated Health Risk

A lower body mass index (BMI) does not protect smokers from fat-associated health risks, according to a Vanderbilt University Medical Center (VUMC) study published in PLOS Medicine.

Read More

Nearly One-Third of Tennessee Parents are Worried Their Child has an Undiagnosed Mental Health Condition, New Poll Finds

One-third of Tennessee parents with children ages 6-17 are worried their child has an undiagnosed mental health condition, a new poll from the Vanderbilt Center for Child Health Policy found.

Read More

COVID-19 - Where We Stand

As the city moves deeper into reopening, leaders address the need for ongoing precautions and realities of vaccine development.

Read More

AMA Issues New Privacy Principles

From a fitness tracker to healthy eating app, data is everywhere ... but it isn't all protected by HIPAA. The AMA has created a set of privacy principles that put patients in charge of their information.

Read More

Paycheck Protection Program Flexibility Act

Deadlines and information on PPP and provider relief fund.

Read More

"What's Up Doc?" Dealing with a Delayed Patient Volume Bounce

Read More

Financing the Deal

The Nashville Health Care Council's annual "Financing the Deal" panel discussion is always highly anticipated. This year's virtual event was as popular as ever with a focus on deal-making trends and strategies.

Read More

Lending a Hand

Mentorship, wisdom offered to start-ups through Nashville Entrepreneur Center.

Read More

Health Care Council Explores the Road to Economic Recovery

Read More

Nashville-Based Startups Launch New Charity Initiatives

Charity-tech brands GeekCause, Generous, Givful and Kindful have jointly announced a range of new initiatives to support the important work of nonprofits during the COVID-19 pandemic.

Read More

Email Print
 
 

 

 


Tags:
FDA, Food & Drug Administration, HELP Committee, Lamar Alexander, Patty Murray, U.S. Senate
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: